NCT00571922 A Clinical Trial of Acamprosate for Treatment of Methamphetamine Addiction Status COMPLETED Phase PHASE1/PHASE2
NCT00571805 Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt Status WITHDRAWN Phase PHASE1/PHASE2
NCT00563212 A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE1
NCT00540046 Immediate vs. Delayed Insertion of Copper T 380A IUD After Termination of Pregnancy Over 12-weeks Gestation Status COMPLETED Phase NA
NCT00537433 Improving Parental Understanding of Medication Instructions Through a Pictogram-Based Intervention Status COMPLETED Phase PHASE1
NCT00531778 NYU Ovarian Cancer Early Detection Program Blood and Genetics Status TERMINATED Phase N/A
NCT00531570 Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian Carcinoma Status COMPLETED Phase N/A
NCT00528437 Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors Status COMPLETED Phase PHASE2
NCT00527683 Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence Status COMPLETED Phase PHASE2
NCT00520299 Study of ADI-PEG 20 in Patients With Advanced Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT00483327 Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate Status COMPLETED Phase PHASE2
NCT00483119 Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus Status TERMINATED Phase PHASE2
NCT00468143 A Within-Subject Cross-Over Comparison Between Immediate Release and Extended Release Adderall Status COMPLETED Phase PHASE4
NCT00463840 Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00444678 Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00418132 Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis Status TERMINATED Phase PHASE1